Preface
Methods in Molecular Biology
; 2547:v-vii, 2022.
Article
in English
| EMBASE | ID: covidwho-2058651
addiction; adverse drug reaction; Alzheimer disease; attention deficit hyperactivity disorder; cancer chemotherapy; cancer immunization; clinical decision making; coronavirus disease 2019; drug delivery system; drug development; drug efficacy; drug safety; drug targeting; drug tolerability; editorial; genetic variability; genetic variation; high throughput sequencing; human; Mendelian randomization analysis; opiate addiction; outcome assessment; pandemic; pediatrics; personalized medicine; pharmacodynamic parameters; pharmacogenetic testing; pharmacogenomics; pharmacokinetic parameters; principal component analysis; rheumatoid arthritis; schizophrenia; systems biology; treatment response; antineoplastic agent; calcium/ec [Endogenous Compound]; cancer vaccine; disease modifying antirheumatic drug; drugs used in the treatment of addiction; G protein coupled receptor/ec [Endogenous Compound]; guanine nucleotide binding protein/ec [Endogenous Compound]; HLA antigen/ec [Endogenous Compound]; neuroleptic agent; nootropic agent; opiate; RNA vaccine
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Methods in Molecular Biology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS